Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2012, Article ID 210210, 10 pages
http://dx.doi.org/10.1155/2012/210210
Review Article

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation

1Division of Cardiology, University Health Network, Toronto General Hospital, Toronto, ON, Canada M5G 2C4
2Multi-Organ Transplant, University Health Network, Toronto General Hospital, Toronto, ON, Canada M5G 2N2
3Histocompatibility Laboratory, University Health Network, Toronto General Hospital, Toronto, ON, Canada M5G 2M1
4Department of Pathology, University Health Network, Toronto General Hospital, Toronto, ON, Canada M5G 2C4
5Division of Cardiac Surgery, University Health Network, Toronto General Hospital, Toronto, ON, Canada M5G 2C4

Received 15 October 2011; Revised 19 December 2011; Accepted 21 December 2011

Academic Editor: Mark Haas

Copyright © 2012 Sharon Chih et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Xin Zhang, Meng Guo, Yindong Kang, Fang Liu, Xueyang Zheng, Shu Han, Shangxi Fu, Shanjuan Hong, Guoshan Ding, and Liming Wang, “SAHA, an HDAC Inhibitor, Attenuates Antibody-Mediated Allograft Rejection,” Transplantation, vol. 96, no. 6, pp. 529–537, 2013. View at Publisher · View at Google Scholar
  • Fatmah M. A. Naemi, Vaughan Carter, John A. Kirby, and Simi Ali, “Anti-Donor HLA Class I Antibodies: Pathways to Endothelial Cell Activation and Cell-Mediated Allograft Rejection,” Transplantation, vol. 96, no. 3, pp. 258–266, 2013. View at Publisher · View at Google Scholar
  • Sofie Verstreken, “Immunosuppressive Management of the Heart Transplant Recipient,” Translational Approach to Heart Failure, pp. 467–489, 2013. View at Publisher · View at Google Scholar
  • Yong Liang, and Haiyan Liu, “Proteasome Inhibition in Transplantation-Focusing on the Experience with Bortezomib,” Current Pharmaceutical Design, vol. 19, no. 18, pp. 3299–3304, 2013. View at Publisher · View at Google Scholar
  • Stephen Cohn, Matthew Dolich, Jay Pal, Daniel DeArmond, Hao Pan, and Scott Johnson, “Complications of Cardiac and Lung Transplantation,” Complications in Surgery and Trauma, Second Edition, pp. 535–546, 2013. View at Publisher · View at Google Scholar
  • Teruhiko Imamura, Koichiro Kinugawa, Naoko Kato, Yukie Kagami, Miyoko Endo, Nobuyuki Kaneko, Shun Minatsuki, Hironori Muraoka, Toshiro Inaba, Hisataka Maki, Masaru Hatano, Kent Doi, Atsushi Yao, Yutaka Takazawa, Minoru Ono, Shunei Kyo, and Issei Komuro, “Successful Treatment of Hemodynamic Compromise Caused by Antibody-Mediated and Cellular Rejection in a Recipient 12 years After Heart Transplantation,” International Heart Journal, vol. 54, no. 5, pp. 328–331, 2013. View at Publisher · View at Google Scholar
  • E. W. Tsai, and E. F. Reed, “MHC class I signaling: new functional perspectives for an old molecule,” Tissue Antigens, vol. 83, no. 6, pp. 375–381, 2014. View at Publisher · View at Google Scholar
  • Kimberly K. Ma, Margaret G. Petroff, Lisa A. Coscia, Vincent T. Armenti, and Kristina M. Adams Waldorf, “Complex chimerism,” Chimerism, vol. 4, no. 3, pp. 71–77, 2014. View at Publisher · View at Google Scholar
  • Thomas Resch, Cornelia Fabritius, Susanne Ebner, Paul Ritschl, and Katja Kotsch, “The Role of Natural Killer Cells in Humoral Rejection,” Transplantation, vol. 99, no. 7, pp. 1335–1340, 2015. View at Publisher · View at Google Scholar
  • Kate S. Arbon, Erin Albers, Mariska Kemna, Sabrina Law, and Yuk Law, “Eosinophil Count, Allergies, and Rejection in Pediatric Heart Transplant Recipients,” The Journal of Heart and Lung Transplantation, 2015. View at Publisher · View at Google Scholar
  • Adriana Luk, Ana Carolina Alba, Jagdish Butany, Kathryn Tinckam, Diego Delgado, and Heather J. Ross, “C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients,” Transplant International, 2015. View at Publisher · View at Google Scholar
  • I. Esme Dijke, “Immunobiology of Transplantation,” Pathology of Transplantation, pp. 7–51, 2016. View at Publisher · View at Google Scholar
  • René P. Michel, and Gerald J. Berry, “Heart Transplantation,” Pathology of Transplantation, pp. 81–119, 2016. View at Publisher · View at Google Scholar
  • Philip T. Thrush, Elfriede Pahl, David C. Naftel, Elizabeth Pruitt, Melanie D. Everitt, Heather Missler, Steven Zangwill, Michael Burch, Timothy M. Hoffman, Ryan Butts, and William T. Mahle, “A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes,” The Journal of Heart and Lung Transplantation, 2016. View at Publisher · View at Google Scholar
  • Stefano Toldo, Mohammed Quader, Fadi Salloum, Eleonora Mezzaroma, and Antonio Abbate, “Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death,” International Journal of Molecular Sciences, vol. 17, no. 6, pp. 958, 2016. View at Publisher · View at Google Scholar
  • Andrzej Chruscinski, Flora Y. Y. Huang, Albert Nguyen, Jocelyn Lioe, Laura C. Tumiati, Stella Kozuszko, Kathryn J. Tinckam, Vivek Rao, Shannon E. Dunn, Michael A. Persinger, Gary A. Levy, and Heather J. Ross, “Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation,” Plos One, vol. 11, no. 3, 2016. View at Publisher · View at Google Scholar
  • M. Farrero Torres, M.J. Pando, C. Luo, H. Luikart, H. Valantine, and K. Khush, “The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation,” Clinical Transplantation, pp. e13121, 2017. View at Publisher · View at Google Scholar
  • Hui Tzu Lin-Wang, Reginaldo Cipullo, João Italo Dias França, Marco Aurelio Finger, Joao Manoel Rossi Neto, Edileide de Barros Correia, Jarbas Jackson Dinkhuysen, and Mário Hiroyuki Hirata, “Intragraft vasculitis and gene expression analysis: Association with acute rejection and prediction of mortality in long-term heart transplantation,” Clinical Transplantation, pp. e13373, 2018. View at Publisher · View at Google Scholar
  • Julieta Lazarte, Mitchell B. Adamson, Laura C. Tumiati, and Diego H. Delgado, “10-Year Experience with HLA-G in Heart Transplantation,” Human Immunology, 2018. View at Publisher · View at Google Scholar
  • Guillaume Coutance, Lucas Van Aelst, Guillaume Hékimian, Charles Vidal, Philippe Rouvier, Samir Saheb, Chantal Gautreau, Pascal Leprince, and Shaida Varnous, “Antibody-mediated rejection induced cardiogenic shock: Too late for conventional therapy,” Clinical Transplantation, pp. e13253, 2018. View at Publisher · View at Google Scholar
  • Yi-Ping Jin, Nicole M. Valenzuela, Xiaohai Zhang, Enrique Rozengurt, and Elaine F. Reed, “HLA Class II–Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection,” The Journal of Immunology, vol. 200, no. 7, pp. 2372–2390, 2018. View at Publisher · View at Google Scholar
  • Umit Kervan, Dogan Emre Sert, and Nesrin Turan, “Humoral Rejection in Cardiac Transplantation: Management of Antibody-Mediated Rejection,” Heart Transplantation, 2018. View at Publisher · View at Google Scholar